Somewhat Favorable News Coverage Somewhat Unlikely to Affect Nu Skin Enterprises (NUS) Share Price

Media stories about Nu Skin Enterprises (NYSE:NUS) have been trending somewhat positive this week, Accern Sentiment reports. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Nu Skin Enterprises earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 45.3268264040039 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Here are some of the headlines that may have effected Accern Sentiment’s rankings:

A number of analysts have issued reports on the stock. ValuEngine upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Tuesday, November 14th. Zacks Investment Research lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $62.00.

Shares of Nu Skin Enterprises (NYSE NUS) traded down $1.57 during trading hours on Friday, reaching $66.34. 404,665 shares of the company’s stock were exchanged, compared to its average volume of 390,547. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.78 and a quick ratio of 1.18. The stock has a market capitalization of $3,492.80, a price-to-earnings ratio of 23.44, a PEG ratio of 2.41 and a beta of 1.57. Nu Skin Enterprises has a one year low of $46.35 and a one year high of $68.50.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Wednesday, November 1st. The company reported $0.76 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.76. The company had revenue of $563.70 million for the quarter, compared to analyst estimates of $562.70 million. Nu Skin Enterprises had a net margin of 6.97% and a return on equity of 22.38%. The business’s revenue for the quarter was down 6.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.98 earnings per share. equities analysts forecast that Nu Skin Enterprises will post 3.23 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 6th. Stockholders of record on Friday, November 17th will be given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.17%. The ex-dividend date is Thursday, November 16th. Nu Skin Enterprises’s dividend payout ratio is presently 52.75%.

In other news, Director Daniel W. Campbell sold 4,607 shares of the business’s stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $62.48, for a total transaction of $287,845.36. Following the completion of the transaction, the director now directly owns 63,753 shares of the company’s stock, valued at $3,983,287.44. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Joseph Y. Chang sold 36,503 shares of the business’s stock in a transaction dated Friday, November 10th. The stock was sold at an average price of $62.24, for a total value of $2,271,946.72. Following the transaction, the insider now directly owns 66,563 shares of the company’s stock, valued at $4,142,881.12. The disclosure for this sale can be found here. Over the last three months, insiders have sold 73,207 shares of company stock valued at $4,585,949. Corporate insiders own 5.20% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect Nu Skin Enterprises (NUS) Share Price” was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of international trademark & copyright law. The correct version of this news story can be read at https://stocknewstimes.com/2017/12/04/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-nu-skin-enterprises-nus-share-price.html.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Insider Buying and Selling by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply